Table 1.
NICE guidance sampling for audit
| Title | Completed | Selected | |
|---|---|---|---|
| Procedure | Wisdom teeth—removal (No 1) | Apr 2000 | Yes |
| Device | Hips—prostheses for primary total hip replacement (No 2) | Mar 2000 | Yes |
| Pharma | Ovarian cancer—taxanes (No 3) | May 2000 | Yes |
| Device | Drug eluting stents (No 4)—obsolete, replaced by No 71 | May 2000 | No |
| Diagnostic | Cervical smear tests—liquid based cytology (No 5)—obsolete, replaced by No 69 | Jun 2000 | No |
| Pharma | Breast cancer—taxanes (No 6) | Jun 2000 | Yes |
| Pharma | Dyspepsia—proton pump inhibitors (No 7) | Jul 2000 | No |
| Device | Hearing disability—new advances in hearing aid technology (No 8)—obsolete, withdrawn | Jul 2000 | Yes |
| Pharma | Diabetes (type 2)—rosiglitazone (No 9)—replaced by No 63 | Aug 2000 | No |
| Device | Asthma—inhalers for children under five (No 10) | Aug 2000 | No |
| Device | Arrhythmias—implantable cardioverter defibrillators (No 11) | Sep 2000 | Yes |
| Pharma | Glycoprotein IIb/IIIa inhibitor guidance for acute coronary syndromes (No 12)—obsolete, replaced by 47 | Sep 2000 | No |
| Pharma | Attention deficit hyperactivity disorder (ADHD)—methylphenidate (No 13) | Oct 2000 | No |
| Pharma | Hepatitis C—interferon alfa and ribavirin (No 14) | Oct 2000 | No |
| Pharma | Flu—zanamivir (Relenza) (No 15)—obsolete, replaced by 58 | Nov 2000 | Yes |
| Procedure | Knee joints (defective)—autologous cartilage transplantation (No 16) | Dec 2000 | No |
| Procedure | Colorectal cancer—laparoscopic surgery (No 17) | Dec 2000 | Yes |
| Procedure | Hernia (inguinal)—laparoscopic surgery (No 18) | Jan 2001 | Yes |
| Pharma | Alzheimer's disease—donepezil, rivastigmine, and galantamine (No 19) | Jan 2001 | Yes |
| Pharma | Motor neurone disease—riluzole (No 20) | Jan 2001 | No |
| Pharma | Diabetes (type 2)—pioglitazone (No 21)—replaced by No 63 | Mar 2001 | No |
| Pharma | Obesity—orlistat (No 22) (last eligible guidance) | Mar 2001 | Yes |